|neuromyelitis optica (NMO)
|We show that expression of 17 miRNAs was significantly higher in untreated NMO patients compared with HCs (all p < 0.05). Following rituximab treatment, the expression levels of 10 of the 17 miRNAs that show increased expression in NMO reverted to the levels seen in HCs.
|Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO).
Copyright © Institution of Biomedical Big Data, Wenzhou Medical University All rights reserved.